Literature DB >> 11401046

Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.

J M Ribaudo1, D Cella, E A Hahn, S R Lloyd, N S Tchekmedyian, J Von Roenn, W T Leslie.   

Abstract

PURPOSE: The original Functional Assessment of Anorexia/Cachexia Therapy (FAACT) was designed to measure general aspects of quality of life (QOL) as well as specific anorexia/cachexia-related concerns. Our primary purpose was to reduce the number of anorexia/cachexia subscale items in a manner that either retains or improves reliability, validity and precision.
METHODS: The FAACT was administered using an interactive computer program that allowed immediate entry of the data. A total of 213 patients were recruited.
RESULTS: A combined empirical and conceptual approach led to the reduction of the anorexia/cachexia subscale (A/CS) from 18 to 12 items. A 26-item trial outcome index (TOI) combining physical well-being (PWB), functional well-being (FWB), and the A/CS-12 was highly reliable and sensitive to change in performance status rating (PSR). We found that PWB, FWB, and A/CS-12 subscales performed differently. Specifically, PWB and FWB scores decreased in patients whose (PSR) worsened. However, although A/CS-12 scores were responsive to change in PSR over time, average A/CS-12 scores of all patients, even those whose PSR worsened, improved over the course of treatment.
CONCLUSIONS: Elimination of six items from the anorexia/cachexia subscale of the FAACT was accomplished without loss of internal consistency or sensitivity to change in performance status. The A/CS-12 subscale provides unique, important information not captured by a generic chronic illness questionnaire.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11401046     DOI: 10.1023/a:1016670403148

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  7 in total

1.  Measuring change over time: assessing the usefulness of evaluative instruments.

Authors:  G Guyatt; S Walter; G Norman
Journal:  J Chronic Dis       Date:  1987

2.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

3.  Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument.

Authors:  W L Ward; E A Hahn; F Mo; L Hernandez; D S Tulsky; D Cella
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

Review 4.  The cancer anorexia-cachexia syndrome.

Authors:  K A Nelson
Journal:  Semin Oncol       Date:  2000-02       Impact factor: 4.929

5.  The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia.

Authors:  D F Cella; J VonRoenn; S Lloyd; H P Browder
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

6.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

7.  Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.

Authors:  D F Cella; A E Bonomi; S R Lloyd; D S Tulsky; E Kaplan; P Bonomi
Journal:  Lung Cancer       Date:  1995-06       Impact factor: 5.705

  7 in total
  44 in total

Review 1.  Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?

Authors:  Maurizio Muscaritoli; Simone Lucia; Alessio Molfino; Tommy Cederholm; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2012-07-08       Impact factor: 3.397

2.  The feasibility, reliability and validity of the McGill Quality of Life Questionnaire-Cardiff Short Form (MQOL-CSF) in palliative care population.

Authors:  Pei Lin Lua; Sam Salek; Ilora Finlay; Chris Lloyd-Richards
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

Review 3.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

4.  Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial.

Authors:  E Del Fabbro; J M Garcia; R Dev; D Hui; J Williams; D Engineer; J L Palmer; L Schover; E Bruera
Journal:  Support Care Cancer       Date:  2013-05-08       Impact factor: 3.603

5.  Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial.

Authors:  Egidio Del Fabbro; Rony Dev; David Hui; Lynn Palmer; Eduardo Bruera
Journal:  J Clin Oncol       Date:  2013-02-25       Impact factor: 44.544

6.  Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).

Authors:  Thomas W LeBlanc; Greg P Samsa; Steven P Wolf; Susan C Locke; David F Cella; Amy P Abernethy
Journal:  Support Care Cancer       Date:  2015-01-14       Impact factor: 3.603

7.  Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments.

Authors:  Janneke van Roij; Heidi Fransen; Lonneke van de Poll-Franse; Myrte Zijlstra; Natasja Raijmakers
Journal:  Qual Life Res       Date:  2018-02-10       Impact factor: 4.147

Review 8.  Early satiety in cancer patients: a common and important but underrecognized symptom.

Authors:  Mellar P Davis; Declan Walsh; Ruth Lagman; Tugba Yavuzsen
Journal:  Support Care Cancer       Date:  2006-04-20       Impact factor: 3.603

9.  Weight changes correlate with alterations in subjective physical function in advanced cancer patients referred to a specialized nutrition and rehabilitation team.

Authors:  Monica P Parmar; Tara Swanson; R Thomas Jagoe
Journal:  Support Care Cancer       Date:  2013-02-26       Impact factor: 3.603

10.  The cancer anorexia-cachexia syndrome: myth or reality?

Authors:  Wael Lasheen; Declan Walsh
Journal:  Support Care Cancer       Date:  2010-02       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.